Skip to main content
Clinical Trials/EUCTR2016-004120-39-SE
EUCTR2016-004120-39-SE
Active, not recruiting
Phase 1

An experimental pilot study on immune and inflammatory biomarkers in patients with advanced prostatecancer treated with degarelix vs. GnRH agonist and with cardiovascular disease

Region Skåne0 sitesJanuary 13, 2017

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Patients with advanced prostate cancer and pre-existing cardiovascular disease
Sponsor
Region Skåne
Status
Active, not recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 13, 2017
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or above
  • Patients with advanced prostate cancer and scheduled for androgen deprivation treatment for at least 8 weeks
  • Patients with a history of cardiovascular disease according to specified criteria
  • Signed informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 10
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 20

Exclusion Criteria

  • Current or prior use in the past 6 months of androgen deprivation therapy
  • Prior use of dutasteride/finasteride or antiandrogen in the past 6 months
  • Ongoing diagnosed chronic or immune disease
  • Known or suspected allergy to medications used in the study
  • QT\-interval at ECG\>450 ms
  • Subject has total bilirubin \>\= 1\.5 x ULN (except subjects with Gilberts disease), or alanine aminotransferase (ALT) or aspartate aminotransferase \>\= 2\.5 x ULN at screening
  • Creatine \> 2 mg/dL (177 umol) at screening

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Acupuncture and reproductive health outcomes: building evidence in an integrated care setting.Immune System HealthReproductive HealthReproductive Health and Childbirth - Fertility including in vitro fertilisationInflammatory and Immune System - Normal development and function of the immune systemAlternative and Complementary Medicine - Other alternative and complementary medicine
ACTRN12609000923268niversity of Western Sydney40
Active, not recruiting
Not Applicable
Exploratory study on inflammatory immune response related to endothelial dysfunction in HIV-infected na?ve patients treated with abacavir compared to tenofovir-based regimens. - ABRACADABRA
EUCTR2009-011662-28-ITAZIENDA OSPEDALIERA SAN GERARDO DI MONZA
Recruiting
Not Applicable
A pilot study to investigate the immunological regulation of preeclampsiaO14Pre-eclampsia
DRKS00025864Carl von Ossietzky Universität Oldenburg/Klinikum Oldenburg; Universitätsklinik für Gynäkologie und Geburtshilfe200
Not yet recruiting
Phase 1
A Pilot Study: Safety and Immunological Response following Intradermal COVID-19 vaccination in The Booster (3rd dose)healthy volunteerSafety and Immunological Response Intradermal COVID-19 vaccination
TCTR20210907003Faculty of Medicine Siriraj Hospital, Mahidol University60
Not yet recruiting
Phase 1
A Pilot Study: Safety and Immunological Response following Intradermal COVID-19 vaccination with Accelerate RegimeHealthy volunteerCOVID-19vaccinesafetyimmunological responseintradermalAccelerate Regimen
TCTR20210904004Health Systems Research Institute (HSRI)60